PT1350510E - Utilizacao de um agente para suprimir a infeccao e proliferacao do virus da virus da sindrome de imunodeficiencia humana - Google Patents
Utilizacao de um agente para suprimir a infeccao e proliferacao do virus da virus da sindrome de imunodeficiencia humanaInfo
- Publication number
- PT1350510E PT1350510E PT02258095T PT02258095T PT1350510E PT 1350510 E PT1350510 E PT 1350510E PT 02258095 T PT02258095 T PT 02258095T PT 02258095 T PT02258095 T PT 02258095T PT 1350510 E PT1350510 E PT 1350510E
- Authority
- PT
- Portugal
- Prior art keywords
- infection
- virus
- proliferation
- immunodeficiency syndrome
- human immunodeficiency
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 4
- 208000033065 inborn errors of immunity Diseases 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 208000028529 primary immunodeficiency disease Diseases 0.000 title abstract 3
- 230000035755 proliferation Effects 0.000 title abstract 3
- 210000002540 macrophage Anatomy 0.000 abstract 4
- 210000001616 monocyte Anatomy 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 2
- 230000001629 suppression Effects 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 238000011225 antiretroviral therapy Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002061788 | 2002-03-07 | ||
| JP2002261024A JP2003327536A (ja) | 2002-03-07 | 2002-09-06 | ヒト免疫不全症候群ウイルスの感染、増殖抑制剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1350510E true PT1350510E (pt) | 2005-09-30 |
Family
ID=28043681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02258095T PT1350510E (pt) | 2002-03-07 | 2002-11-25 | Utilizacao de um agente para suprimir a infeccao e proliferacao do virus da virus da sindrome de imunodeficiencia humana |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7034005B2 (pt) |
| EP (1) | EP1350510B1 (pt) |
| JP (1) | JP2003327536A (pt) |
| KR (1) | KR20030074097A (pt) |
| CN (1) | CN1183915C (pt) |
| AT (1) | ATE295729T1 (pt) |
| AU (1) | AU2002302115B2 (pt) |
| CA (1) | CA2412065A1 (pt) |
| DE (1) | DE60204211T2 (pt) |
| DK (1) | DK1350510T3 (pt) |
| ES (1) | ES2241967T3 (pt) |
| MX (1) | MXPA02012320A (pt) |
| PT (1) | PT1350510E (pt) |
| RU (1) | RU2250770C2 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2043661B1 (en) * | 2006-07-13 | 2014-10-01 | Eco Animal Health Ltd | Use of tylvalosin as antiviral agent |
| EP1911836A1 (en) * | 2006-10-12 | 2008-04-16 | AVIR Green Hills Biotechnology Trading GmbH | Medium supplement for virus production |
| GB0701253D0 (en) | 2007-01-23 | 2007-02-28 | Diagnostics For The Real World | Nucleic acid amplification and testing |
| WO2012021964A1 (en) * | 2010-08-18 | 2012-02-23 | UNIVERSITé LAVAL | Compounds and therapeutic applications related to inhibition of dendritic cell immunoreceptor (dcir) activity and signaling events |
| CA2961464A1 (en) * | 2014-09-16 | 2016-03-24 | Ubi Ip Holdings | Treatment and functional cure of hiv infection by monoclonal antibodies to cd4 mediating competitive hiv entry inhibition |
| KR20190071677A (ko) | 2016-08-13 | 2019-06-24 | 유나이티드 바이오파마, 인크. | Haart 안정화된 환자에서 cd4에 대한 항체에 의한 hiv 감염의 치료 및 지속적 바이러스 완화 |
| US11059846B2 (en) | 2017-02-22 | 2021-07-13 | ISR Immune System Regulation Holding AB (publ) | Immune stimulating compound |
| WO2018153954A1 (en) | 2017-02-22 | 2018-08-30 | Immune System Regulation Holding Ab | Novel immune stimulating macrolide |
| EP3585796B1 (en) | 2017-02-22 | 2021-06-16 | ISR Immune System Regulation Holding AB (publ) | Novel immune stimulating macrolides |
| CN110678476A (zh) | 2017-02-22 | 2020-01-10 | 免疫系统调节控股有限公司 | 新型免疫刺激大环内酯 |
| AU2019237257A1 (en) | 2018-03-23 | 2020-10-15 | ISR Immune System Regulation Holding AB (publ) | Combinations of macrolide compounds and immune checkpoint inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0254534A3 (en) | 1986-07-24 | 1991-04-17 | William S. Robinson | Erythromycin derivatives and compositions and use for inhibiting virus replication and disease |
| US5106961A (en) * | 1987-05-26 | 1992-04-21 | Eli Lilly And Company | Erythromycin ring-contracted derivatives |
| US5312837A (en) * | 1991-01-29 | 1994-05-17 | Genelabs Technologies, Inc. | Method of treating viral infections with aryl macrocyclic compounds |
| US5541193A (en) | 1991-09-05 | 1996-07-30 | Abbott Laboratories | Heterocycle-containing macrocyclic immunomodulators |
| FR2683723B1 (fr) | 1991-11-14 | 1995-05-19 | Mayoly Spindler Laboratoires | Nouveaux medicaments antiviraux actifs sur le virus vih. |
| WO1994025038A1 (en) * | 1993-05-05 | 1994-11-10 | Palo Alto Medical Foundation | Use of rifamycin derivatives for the manufacture of a medicament for the treatment of toxoplasmosis |
| US5545734A (en) | 1994-10-25 | 1996-08-13 | Merck & Co., Inc. | Aryl and heteroaryl macrolides having immunosuppressive activity |
| US6107327A (en) * | 1996-08-30 | 2000-08-22 | Eli Lilly And Company | Therapeutic treatment for HIV infection |
| TR200002771T2 (tr) | 1998-03-26 | 2001-02-21 | Fujisawa Pharmaceutical Co.,Ltd. | Devamlı salımı olan preparatlar |
| KR20040066186A (ko) * | 2000-08-17 | 2004-07-23 | 샤단호칭키타사토겐큐쇼 | 신규 슈도에리쓰로마이신 유도체 |
-
2002
- 2002-09-06 JP JP2002261024A patent/JP2003327536A/ja active Pending
- 2002-11-15 US US10/294,587 patent/US7034005B2/en not_active Expired - Fee Related
- 2002-11-18 CA CA002412065A patent/CA2412065A1/en not_active Abandoned
- 2002-11-20 RU RU2002131253/15A patent/RU2250770C2/ru not_active IP Right Cessation
- 2002-11-21 AU AU2002302115A patent/AU2002302115B2/en not_active Ceased
- 2002-11-21 KR KR1020020072632A patent/KR20030074097A/ko not_active Ceased
- 2002-11-25 ES ES02258095T patent/ES2241967T3/es not_active Expired - Lifetime
- 2002-11-25 DE DE60204211T patent/DE60204211T2/de not_active Expired - Fee Related
- 2002-11-25 AT AT02258095T patent/ATE295729T1/de not_active IP Right Cessation
- 2002-11-25 EP EP02258095A patent/EP1350510B1/en not_active Expired - Lifetime
- 2002-11-25 DK DK02258095T patent/DK1350510T3/da active
- 2002-11-25 PT PT02258095T patent/PT1350510E/pt unknown
- 2002-12-11 CN CNB021559244A patent/CN1183915C/zh not_active Expired - Fee Related
- 2002-12-13 MX MXPA02012320A patent/MXPA02012320A/es active IP Right Grant
-
2005
- 2005-09-23 US US11/232,930 patent/US20060025357A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1443538A (zh) | 2003-09-24 |
| CA2412065A1 (en) | 2003-09-07 |
| AU2002302115A1 (en) | 2003-09-25 |
| DK1350510T3 (da) | 2005-08-29 |
| ES2241967T3 (es) | 2005-11-01 |
| DE60204211D1 (de) | 2005-06-23 |
| US20030186900A1 (en) | 2003-10-02 |
| US7034005B2 (en) | 2006-04-25 |
| MXPA02012320A (es) | 2004-12-13 |
| US20060025357A1 (en) | 2006-02-02 |
| KR20030074097A (ko) | 2003-09-19 |
| JP2003327536A (ja) | 2003-11-19 |
| EP1350510A1 (en) | 2003-10-08 |
| RU2250770C2 (ru) | 2005-04-27 |
| CN1183915C (zh) | 2005-01-12 |
| HK1056838A1 (en) | 2004-03-05 |
| EP1350510B1 (en) | 2005-05-18 |
| AU2002302115B2 (en) | 2004-11-04 |
| ATE295729T1 (de) | 2005-06-15 |
| DE60204211T2 (de) | 2006-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU23208A3 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea | |
| TR199903053T2 (xx) | Benzimidazol t�revleri. | |
| BR9911071A (pt) | Preparações para aplicação de agentes antiinflamatórios, especialmente anti-sépticos e/ou agentes promotores da cura de feridas no trato respiratório superior e/ou no ouvido | |
| PT1350510E (pt) | Utilizacao de um agente para suprimir a infeccao e proliferacao do virus da virus da sindrome de imunodeficiencia humana | |
| PL365285A1 (en) | Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs | |
| ATE493981T1 (de) | Einmal tägliche dosierformen von trospium | |
| EA200870183A1 (ru) | Долговременное лечение вич-инфекции | |
| DE69322251D1 (de) | Medizinische zusammensetzung | |
| EA201992336A1 (ru) | Фармацевтическая композиция, включающая дисульфид глутатиона и глутатион дисульфид s-оксид | |
| BR0210744A (pt) | Combinação farmacêutica sinergìstica para a prevenção ou tratamento de diabetes | |
| CO5251425A1 (es) | Metodo y composiciones para administrar taxanos oralmente a pacientes humanos | |
| NZ324380A (en) | Therapeutic benzimidazole compounds and their use in treatment of virus infections | |
| CA2504872A1 (en) | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections | |
| BRPI0407140A (pt) | Droga terapêutica para vìrus | |
| TR200102512T2 (tr) | Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı. | |
| AR045070A1 (es) | Preparados farmaceuticos topicos de acido ascorbico con efecto post-antimicotico | |
| BR9712614A (pt) | Composição farmacêutica,processos para aumentar e manter a homogeneidade de uma composição farmac&eutica,para tratar,reverter,reduzir ou inibir infeccões retrovirais e para preparação de uma composição farmacêutica,uso de lamivudina ou de um derivado farmaceuticamenete aceitável da mesma,de zidovudina,ou de um derivado farmaceuticamente aceitável da mesma e de um agente de deslizamento farmaceuticamente aceitável,e, artigo de amnufatura. | |
| WO2004033479A3 (en) | Retroyclins: antiviral and antimicrobial peptides | |
| ES2148234T3 (es) | Composicion farmaceutica a base de flavopereirina y su utilizacion en el tratamiento del virus vih. | |
| DE60025826D1 (de) | Pyrazolidinol-verbindungen | |
| PT1411956E (pt) | Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih | |
| Ostenson | Lap burn due to laptop computer | |
| WO2003043632A3 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
| ATE374033T1 (de) | Gebrauchsfertige gemcitabin-lösungen | |
| DK1143976T3 (da) | Beta-D-2', 3'-didehydro-2', 3'-dideoxy-5-fluorcytidin til anvendelse i behandlingen af HIV-infektioner |